Diabetes cell therapies take evasive action

Elie Dolgin • February 25, 2022

Protective encapsulating devices and gene-editing technologies could obviate the need for antirejection drugs in stem-cell-derived therapies for diabetes.

Continue reading at Nature Biotechnology.

‘Connectoids’ use microfluid channels to recapitulate and study neural connections.
By Elie Dolgin May 14, 2025
With organoids, assembloids and a growing bioengineering toolkit, scientists are pushing the limits of human brain models.
Picture of scientist handling mRNA, Robert F. Kennedy Jr. and vaccine protesters.
By Elie Dolgin May 9, 2025
Drug makers are scrambling to navigate an ‘existential threat’ to a once-celebrated technology.